The diabetes market in India is a significant and growing segment of the Indian healthcare industry. According to a report by the International Diabetes Federation, India had an estimated 77 million adults living with diabetes in 2019, the country with the second-highest number of diabetes cases after China.
The diabetes market in India includes various products and services, including medications, medical devices, and diagnostic tests. The market is dominated by multinational pharmaceutical companies which offer a range of insulin products and oral diabetes medications.
Here we talk about the diabetes market in India is expected to continue to grow in the coming years, driven by factors such as the increasing prevalence of diabetes, rising healthcare expenditure, and the adoption of innovative digital health solutions.
